📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Fabrus

1.1 - Company Overview

Fabrus Logo

Fabrus

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of functional therapeutic monoclonal antibody discovery and development targeting challenging cell surface proteins, including GPCRs and ion channels, supported by a unique antibody discovery platform and multiple preclinical lead candidates against important cancer targets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Fabrus

Oncimmune Logo

Oncimmune

HQ: United Kingdom Website
  • Description: Provider of proprietary autoantibody assay technologies for early cancer detection, offering ImmunoINSIGHTS analytical platform to discover and profile autoantibody biomarkers for disease characterization, patient stratification, and response prediction; biomarker discovery services; customizable targeted panels and arrays for immuno-oncology and autoimmune diseases; and bioinformatics and data science with multiomics integration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oncimmune company profile →
Piramed Logo

Piramed

HQ: United Kingdom Website
  • Description: Provider of inhibitor-focused drug discovery and development of new medicines targeting cancer and immune inflammatory disorders, with applications across cardiovascular disease and pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Piramed company profile →
Origo Biopharma Logo

Origo Biopharma

HQ: Spain Website
  • Description: Provider of research and development of immunotherapeutic products targeting health disorders related to TGF-beta signaling dysfunction, including cancer and fibrosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Origo Biopharma company profile →
Zyngenia Logo

Zyngenia

HQ: United States Website
  • Description: Provider of biotherapeutics focused on the development of next-generation antibody-derived drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zyngenia company profile →
Precede Bio Logo

Precede Bio

HQ: United States Website
  • Description: Provider of liquid biopsy and epigenomic profiling solutions that analyze circulating chromatin and the DNA methylome from 1 mL of plasma to evaluate gene and pathway activation. Offerings include blood-based diagnostic tests for precision use of cancer medicines as a minimally invasive alternative to tissue biopsies, an assay revealing disease biology and therapeutic targets for research and therapy selection, and a RUO platform for drug developers and academic researchers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precede Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Fabrus

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Fabrus

2.2 - Growth funds investing in similar companies to Fabrus

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Fabrus

4.2 - Public trading comparable groups for Fabrus

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Fabrus

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Fabrus

What does Fabrus do?

Fabrus is a provider of functional therapeutic monoclonal antibody discovery and development targeting challenging cell surface proteins, including GPCRs and ion channels, supported by a unique antibody discovery platform and multiple preclinical lead candidates against important cancer targets.

Who are Fabrus's competitors?

Fabrus's competitors and similar companies include Oncimmune, Piramed, Origo Biopharma, Zyngenia, and Precede Bio.

Where is Fabrus headquartered?

Fabrus is headquartered in United States.

How many employees does Fabrus have?

Fabrus has 1,000 employees 🔒.

When was Fabrus founded?

Fabrus was founded in 2010 🔒.

What sector and industry vertical is Fabrus in?

Fabrus is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Fabrus

Who are the top strategic acquirers in Fabrus's sector and industry

Top strategic M&A buyers and acquirers in Fabrus's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Fabrus?

Top strategic M&A buyers groups and sectors for Fabrus include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Fabrus's sector and industry vertical

Which are the top PE firms investing in Fabrus's sector and industry vertical?

Top PE firms investing in Fabrus's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Fabrus's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Fabrus's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Fabrus's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Fabrus include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Fabrus's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Fabrus?

The key public trading comparables and valuation benchmarks for Fabrus include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Fabrus for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Fabrus with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Fabrus's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Fabrus with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Fabrus's' sector and industry vertical?

Access recent funding rounds and capital raises in Fabrus's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Fabrus

Launch login modal Launch register modal